Inventor
LONG DANIEL D
US103 patents
⚠️ This page may combine multiple inventors who share the name “LONG DANIEL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
26 patentsUS7375114B2May 20, 2008
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC41 citations96
US7341993B2Mar 11, 2008
Cross-linked glycopeptide—cephalosporin antibiotics
THERAVANCE INC22 citations96
US6974797B2Dec 13, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC45 citations96
US6878686B2Apr 12, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC49 citations96
US7067481B2Jun 27, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC41 citations95
US7622508B2Nov 24, 2009
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC39 citations94
US8377964B2Feb 19, 2013
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations93
US7759363B2Jul 20, 2010
Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC18 citations93
US7592355B2Sep 22, 2009
Quinolinone-carboxamide compounds as 5-HT, receptor agonists
THERAVANCE INC13 citations93
US7317022B2Jan 8, 2008
Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists
THERAVANCE INC19 citations93
US7902220B2Mar 8, 2011
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
THERAVANCE INC14 citations92
US7763637B2Jul 27, 2010
Quinolinone-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC12 citations92
US7419989B2Sep 2, 2008
Indazole-carboxamide compounds
THERAVANCE INC19 citations92
US7399862B2Jul 15, 2008
5-HT4 receptor agonist compounds
THERAVANCE INC26 citations92
US7396933B2Jul 8, 2008
Quinolinone-carboxamide compounds
THERAVANCE INC28 citations92
US7351704B2Apr 1, 2008
Indazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC25 citations92
US7332471B2Feb 19, 2008
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC21 citations92
US6995138B2Feb 7, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC34 citations92
US7947710B2May 24, 2011
Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC9 citations84
US7932402B2Apr 26, 2011
Process for preparing an intermediate to opioid receptor antagonists
THERAVANCE INC8 citations84
US7728006B2Jun 1, 2010
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC11 citations84
US7691878B2Apr 6, 2010
Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC13 citations84
US7534889B2May 19, 2009
5-HT4 receptor agonist compounds
THERAVANCE INC13 citations84
US7498442B2Mar 3, 2009
Quinolinone-carboxamide compounds
THERAVANCE INC10 citations84
US7446114B2Nov 4, 2008
Quinolinone compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations84
US7902221B2Mar 8, 2011
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE INC10 citations82
LONG DANIEL D
6 patentsUS9663509B2May 30, 2017
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D10 citations92
US9206172B2Dec 8, 2015
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D10 citations92
US8927573B2Jan 6, 2015
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D10 citations92
US8664242B2Mar 4, 2014
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D13 citations92
US8263618B2Sep 11, 2012
8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
LONG DANIEL D18 citations92
US8518966B2Aug 27, 2013
Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
LONG DANIEL D6 citations83
THERAVANCE BIOPHARMA R&D IP LLC
6 patentsUS11634419B2Apr 25, 2023
Dimethyl amino azetidine amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC6 citations84
US10947229B2Mar 16, 2021
Dimethyl amino azetidine amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC10 citations84
US10836763B2Nov 17, 2020
5 to 7 membered heterocyclic amides as JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC12 citations84
US10377751B2Aug 13, 2019
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10081626B2Sep 25, 2018
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC5 citations84
US11155549B2Oct 26, 2021
Ester and carbonate pyrimidine compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC5 citations81
PATTERSON LORI JEAN
3 patentsUS9162982B2Oct 20, 2015
4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds
PATTERSON LORI JEAN15 citations96
US8604058B2Dec 10, 2013
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN20 citations96
US8304432B2Nov 6, 2012
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN25 citations96
MCKINNELL ROBERT MURRAY
3 patentsUS8143279B2Mar 27, 2012
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
MCKINNELL ROBERT MURRAY9 citations91
US9428489B2Aug 30, 2016
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
MCKINNELL ROBERT MURRAY6 citations83
US8921372B2Dec 30, 2014
Inhibitors of hepatitis C virus
MCKINNELL ROBERT MURRAY8 citations82
MARQUESS DANIEL
2 patentsSAITO DAISUKE ROLAND
2 patentsCOLSON PIERRE-JEAN
1 patentTRAPP SEAN G
1 patentShowing the top 50 of 103 patents by PatentIndex Score.